CCXI

ChemoCentryx News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
ChemoCentryx Inc CCXI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.66 4.13% 16.65 20:00:00
Open Price Low Price High Price Close Price Prev Close
16.00 15.81 16.75 16.57 15.99
more quote information »

Recent News

Date Time Source Heading
9/10/202115:00SEEKCatalyst watch for next week: Apple, Zoom Video, Palo Alto..
9/02/202108:30GLOBEChemoCentryx to Participate in Two Upcoming Investor..
8/10/202116:04EDGARSecurities Registration: Employee Benefit Plan (s-8)
8/09/202116:47EDGARQuarterly Report (10-q)
8/09/202116:34EDGARCurrent Report Filing (8-k)
8/09/202116:05GLOBEChemoCentryx Reports Second Quarter 2021 Financial Results..
8/04/202108:30GLOBEChemoCentryx to Participate in the Canaccord Genuity 41st..
8/02/202108:30GLOBEChemoCentryx to Hold Second Quarter 2021 Financial Results..
7/09/202116:31TRMNChemocentryx: A Risky Yet Potentially Lucrative Bet
7/06/202113:19DJNChemoCentryx Shares Rise 10% After Filing NDA Amendment for..
7/06/202110:06EDGARCurrent Report Filing (8-k)
7/06/202109:54DJNChemoCentryx Files Amendment to Avacopan NDA
7/06/202108:55SEEKChemoCentryx stock soars 15% after filing an amendment to..
7/06/202108:30GLOBEChemoCentryx Announces Filing of Amendment to NDA Submission..
6/16/202119:02EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202108:30GLOBEChemoCentryx to Participate in the Raymond James 2021 Human..
6/11/202112:19SEEKChemoCentryx continues winning streak amid looming legal..
6/09/202107:52EDGARSchedule 13g
6/08/202108:30GLOBEChemoCentryx Announces Abstract on Avacopan in..
5/24/202119:55EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202119:40EDGARStatement of Changes in Beneficial Ownership (4)
5/24/202112:54EDGARCurrent Report Filing (8-k)
5/10/202119:49EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202116:31TRMNIs Chemocentryx Stock a Buy Right Now? This Is What You Need..
5/07/202114:57EDGARCurrent Report Filing (8-k)
5/07/202106:45SEEKChemoCentryx reports outcome of FDA’s expert panel meeting..
5/06/202123:37GLOBEChemoCentryx Announces Results of FDA Advisory Committee..
5/06/202117:15SEEKFDA panel split 9-9 on efficacy for Chemocentryx's..
5/04/202112:20SEEKChemocentryx shares plunge 47% as FDA report identifies..
5/03/202106:05EDGARQuarterly Report (10-q)
4/29/202116:26SEEKChemoCentryx EPS misses by $0.03, beats on revenue
4/29/202116:20EDGARCurrent Report Filing (8-k)
4/29/202116:05GLOBEChemoCentryx Reports First Quarter 2021 Financial Results..
4/22/202108:30GLOBEChemoCentryx to Hold First Quarter 2021 Financial Results..
4/09/202108:30GLOBEChemoCentryx’s Oral PD-L1 inhibitor, CCX559, Featured in..
4/07/202116:10EDGARProxy Statement (definitive) (def 14a)
4/07/202108:30GLOBEChemoCentryx to Host Virtual R&D Day on April 14, 2021
3/08/202108:30GLOBEChemoCentryx Announces Appointment of Susan M. Kanaya to..
3/03/202116:17EDGARCurrent Report Filing (8-k)
3/01/202116:52EDGARCurrent Report Filing (8-k)
3/01/202116:38EDGARAnnual Report (10-k)
3/01/202116:20EDGARCurrent Report Filing (8-k)
3/01/202116:16SEEKChemoCentryx EPS misses by $0.10, misses on revenue
3/01/202116:05GLOBEChemoCentryx Reports Fourth Quarter and Full Year 2020..
2/25/202108:30GLOBEChemoCentryx to Present at Two Upcoming Investor Conferences
2/24/202112:13EDGARInitial Statement of Beneficial Ownership (3)
2/24/202109:11SEEKChemoCentryx names new EVP & COO
2/24/202108:30GLOBEChemoCentryx Appoints Tausif (‘Tosh’) Butt as Executive Vice..
2/23/202108:30GLOBEChemoCentryx to Hold Fourth Quarter and Full Year 2020..
2/18/202109:15SEEKChemoCentryx announces peer reviewed publication of Phase 3..
See more news about this stock »


Your Recent History
NASDAQ
CCXI
ChemoCentr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.